BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lin SY, Zhang A, Lian J, Wang J, Chang TT, Lin YJ, Song W, Su YH. Recurrent HBV Integration Targets as Potential Drivers in Hepatocellular Carcinoma. Cells 2021;10:1294. [PMID: 34071075 DOI: 10.3390/cells10061294] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Oda C, Kamimura K, Shibata O, Morita S, Tanaka Y, Setsu T, Abe H, Yokoo T, Sakamaki A, Kamimura H, Kofuji S, Wakai T, Nishina H, Terai S. HBx and YAP expression could promote tumor development and progression in HBV-related hepatocellular carcinoma. Biochemistry and Biophysics Reports 2022;32:101352. [DOI: 10.1016/j.bbrep.2022.101352] [Reference Citation Analysis]
2 Salpini R, D’anna S, Benedetti L, Piermatteo L, Gill U, Svicher V, Kennedy PTF. Hepatitis B virus DNA integration as a novel biomarker of hepatitis B virus-mediated pathogenetic properties and a barrier to the current strategies for hepatitis B virus cure. Front Microbiol 2022;13:972687. [DOI: 10.3389/fmicb.2022.972687] [Reference Citation Analysis]
3 Linden N, Jones RB. Potential multi-modal effects of provirus integration on HIV-1 persistence: lessons from other viruses. Trends Immunol 2022:S1471-4906(22)00117-X. [PMID: 35817699 DOI: 10.1016/j.it.2022.06.001] [Reference Citation Analysis]